ClinicalTrials.Veeva

Menu

Finnish Patient-Reported Outcomes Initiative for Shoulder and Elbow (φ-PROMISE)

H

Helsinki University Central Hospital (HUCH)

Status

Enrolling

Conditions

Definition of the Minimal Important Difference
Definition of the Patients Acceptable Symptomatic State
Cultural Adaptation of Shoulder and Elbow PROMs

Treatments

Procedure: Surgical or non-surgical treatment

Study type

Observational

Funder types

Other

Identifiers

NCT05598541
HUS/715/2021

Details and patient eligibility

About

The purpose of φ-PROMISE project is to carry out a cultural adaptation (translate into Finnish and validate) some of the most frequently used shoulder- and elbow-specific patient-reported outcome measures, PROMs. In addition, we aim to investigate which outcome measures are the most relevant for assessing the severity of complaints and treatment outcomes. Also, we will define the Patients Acceptable Symptomatic State (PASS) and the Minimal Important Difference (MID) of the individual outcome measures.

Enrollment

600 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Orthopedic outpatient visit at the Helsinki University Hospital
  • Signed informed consent
  • Age over 18 years
  • Finnish as language of communication

Exclusion criteria

  • Recent surgery (within 2 months)
  • Insufficient compliance

Trial design

600 participants in 2 patient groups

Shoulder
Description:
Patients with shoulder problems presenting to the orthopaedic outpatient clinic of the Helsinki University Hospital
Treatment:
Procedure: Surgical or non-surgical treatment
Elbow
Description:
Patients with elbow problems presenting to the orthopaedic outpatient clinic of the Helsinki University Hospital
Treatment:
Procedure: Surgical or non-surgical treatment

Trial contacts and locations

1

Loading...

Central trial contact

Thomas Ibounig, MD; Saara Raatikainen

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems